Imeik Technology Development Co (300896) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
9M 2026 revenue fell 6.48% YoY to ¥1.744bn; net profit attributable to shareholders declined 27.64% to ¥791.1m.
Q3 revenue declined 6.62% YoY to ¥528.3m, while attributable net profit fell 34.92% to ¥197.7m.
Financial highlights
9M operating revenue was ¥1.744bn versus ¥1.865bn a year earlier; operating profit was ¥944.3m versus ¥1.283bn.
9M consolidated net profit was ¥801.2m; attributable net profit was ¥791.1m, down 27.64% YoY.
9M adjusted net profit, excluding non-recurring gains and losses, was ¥701.7m, down 26.35% YoY; Q3 adjusted net profit was ¥170.5m, down 31.62%.
9M operating costs and expenses totaled ¥897.4m, compared with ¥740.4m in the prior-year period.
Key financial ratios and metrics
9M basic and diluted EPS were ¥2.62, down 27.82% YoY; Q3 basic and diluted EPS were ¥0.66, down 34.65%.
9M weighted average ROE was 10.08%, down 4.1 percentage points YoY; Q3 ROE was 2.46%, down 1.54 percentage points.
At September 30, total assets were ¥9.021bn, up 1.27% from year-end 2025; equity attributable to shareholders was ¥7.843bn, up 3.42%.
Latest events from Imeik Technology Development Co
- Revenue and profit fell, but margins stayed high and new products boosted future growth.300896
Q2 2026 - Q1 2026 saw lower revenue and profit amid rising costs and legal uncertainties.300896
Q1 2026 - Revenue and profit fell, but global expansion and new products support long-term growth.300896
Q4 2025 - Revenue and profit declined significantly, impacted by costs and acquisition-related changes.300896
Q3 2025 - Revenue and profit fell, but global expansion and high margins support long-term growth.300896
Q2 2025 - Revenue and net profit rose year-over-year, while EPS declined due to share capital expansion.300896
Q3 2024 - Revenue and net profit grew over 13% and 16% year-over-year, driven by strong core product sales.300896
Q2 2024 - Q1 2025 saw double-digit declines in revenue and profit amid a tough market environment.300896
Q1 2025 - Revenue and net profit rose over 5% year-over-year, with high margins and strong R&D investment.300896
Q4 2024